ArticleAntibiotics (Basel, Switzerland)2022

Treatment Outcomes of Tocilizumab in Critically-Ill COVID-19 Patients, Single-Centre Retrospective Study.

Wael Hafez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.